drugset / Trial / NCT00626522
Aclidinium/Formoterol Fixed Combination Dose Finding Study
RandomizedParallel-groupDouble-blindTreatment
Summary
The study seeks to determine the optimal dose of the Aclidinium/Formoterol combination for investigation in Phase III clinical trials
Timeline
- Start
- 2008-02
- Primary completion
- 2008-11
- Completion
- 2008-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aclidinium | Small molecule | — | Inhaled |
| Subject | Formoterol | Other / unclassified | — | Inhaled |